PRESTIGE BIOLOGICS CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3,990 KRW | -0.62% |
|
-3.74% | -9.32% |
Prestige Biologics Co Ltd is a Korean-based company mainly engaged in the business of developing and manufacturing biopharmaceuticals. The Company mainly engages in the contract manufacturing service business that produces and supplies biopharmaceuticals; and contract development service business that provides development services including cell culture process and purification process.
Sector
Pharmaceuticals
Calendar
12/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -9.32% | 178M | |
| +2.99% | 95.18B | |
| -4.34% | 37.55B | |
| -10.41% | 33.75B | |
| +75.79% | 28.2B | |
| -14.61% | 15.63B | |
| -3.46% | 13.63B | |
| -12.31% | 11.5B | |
| +184.77% | 10.81B | |
| -54.13% | 9.23B |
- Stock Market
- Equities
- A334970 Stock
- Funds and ETFs Prestige Biologics Co., Ltd.
